The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

Shares in the $247 bln obesity drugmaker fell over 20% after it said sales would grow more slowly than expected. Competition ...

Pedersen, Stine Jacobsen and Maggie Fick COPENHAGEN (Reuters) -Investors knocked $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit ...